Table 1 Clinical characteristics at hospital admission of COVID-19 dying individuals according to sex
| Â | Overall (n = 3517) | Women (n = 1171) | Men (n = 2346) | p value |
|---|---|---|---|---|
Age, years (mean ± SD) | 77.64 ± 11.51 | 80.40 ± 11.41 | 76.26 ± 11.32 | < 0.001 |
Age tertiles, n (%) | ||||
 1° (age < 75 years) | 1210 (34.4) | 300 (25.6) | 910 (38.8) | < 0.001 |
 2° (75–84 years) | 1285 (36.5) | 383 (32.7) | 902 (38.4) | |
 3° (> 84 years) | 1022 (29.1) | 488 (41.7) | 534 (22.8) | |
Area of COVID-19 diffusion, n (%)b | ||||
 High | 2547 (72.6) | 826 (70.8) | 1721 (73.5) | 0.23 |
 Intermediate | 790 (22.5) | 279 (23.9) | 511 (21.8) | |
 Low | 172 (4.9) | 62 (5.3) | 110 (4.7) | |
Comorbidities, n (%)a | ||||
 Ischemic heart disease | 957 (27.8) | 236 (20.8) | 721 (31.3) | < 0.001 |
 Atrial fibrillation | 758 (22.0) | 260 (22.9) | 498 (21.6) | 0.43 |
 Congestive heart failure | 539 (15.7) | 209 (17.8) | 330 (14.1) | 0.002 |
 Stroke | 349 (10.2) | 118 (10.4) | 231 (10.0) | 0.76 |
 Hypertension | 2305 (67.0) | 774 (68.1) | 1531 (66.5) | 0.37 |
 Type-2 diabetes mellitus | 1040 (30.3) | 322 (28.3) | 718 (31.2) | 0.09 |
 Dementia | 562 (16.3) | 266 (23.4) | 296 (12.9) | < 0.001 |
 Chronic obstructive pulmonary disease | 576 (16.8) | 143 (12.6) | 433 (18.8) | < 0.001 |
 Active cancer | 551 (16.0) | 185 (16.3) | 366 (15.9) | 0.80 |
 Chronic liver disease | 148 (4.3) | 37 (3.3) | 111 (4.8) | 0.032 |
 Chronic renal disease | 688 (20.0) | 200 (17.6) | 488 (21.2) | 0.013 |
 Dialysis | 67 (1.9) | 19 (1.7) | 48 (2.1) | 0.43 |
 Respiratory failure | 180 (5.2) | 61 (5.4) | 119 (5.2) | 0.81 |
 HIV | 7 (0.2) | 0 (0.0) | 7 (0.3) | 0.10 |
 Autoimmune disease | 137 (4.0) | 67 (5.9) | 70 (3.0) | < 0.001 |
 Obesity | 377 (11.0) | 127 (11.2) | 250 (10.9) | 0.82 |
No. of comorbidities, n (%) | ||||
 0 | 144 (4.2) | 33 (2.9) | 111 (4.8) | 0.54 |
 1 | 505 (14.7) | 161 (14.2) | 344 (15.0) | |
 2 | 738 (21.5) | 250 (22.0) | 488 (21.2) | |
 ≥ 3 | 2051 (59.6) | 693 (60.9) | 1358 (59.0) | |